The University of Southampton
University of Southampton Institutional Repository

Systematic review of the nutritional supplement Perna Canaliculus (green-lipped mussel) in the treatment of osteoarthritis

Brien, S., Prescott, P., Coghlan, B., Bashir, N. and Lewith, G. (2008) Systematic review of the nutritional supplement Perna Canaliculus (green-lipped mussel) in the treatment of osteoarthritis QJM: An International Journal of Medicine, 101, (3), pp. 167-179. (doi:10.1093/qjmed/hcm108).

Record type: Article

Abstract

Complementary treatments for osteoarthritis (OA) are sought by patients for symptomatic relief and to avoid the iatrogenic effects of non-steroidal anti-inflammatories. This systematic review evaluates the efficacy of the nutritional supplement Perna Canaliculus (green-lipped mussel, GLM) in the treatment of OA and substantially adds to previous work by focussing solely on GLM use in OA as well providing a re-analysis of the original trial data. Randomized or quasi-randomized controlled trials (comparative, placebo-controlled or crossover) were considered for inclusion from Cochrane Library, Medline, Embase, Amed, Cinahl, Scopus and NeLH databases where adults with OA of any joint were randomized to receive either GLM vs. placebo, no additional intervention (usual care), or an active intervention. The methodological quality of the trials was assessed using the JADAD scale. Four RCTs were included, three placebo controlled, the fourth a comparative trial of GLM lipid extract vs. stabilized powder extract. No RCTs comparing GLM to conventional treatment were identified. All four studies assessed GLM as an adjunctive treatment to conventional medication for a clinically relevant time in mild to moderate OA. All trials reported clinical benefits in the GLM treatment group but the findings from two studies cannot be included in this review because of possible un-blinding and inappropriate statistical analysis. The data from the two more rigorous trials, in conjunction with our re-analysis of original data suggests that GLM may be superior to placebo for the treatment of mild to moderate OA. As a credible biological mechanism exists for this treatment, further rigorous investigations are required to assess efficacy and optimal dosage.

Full text not available from this repository.

More information

Published date: 2008
Keywords: osteoarthritis, medline, scale, time, controlled-trial, complementary, placebo, primary-care, England, care, analysis, adult, review, extract, adults, trial, efficacy, clinical-trials, treatment, systematic review, quality, arthritis, seatone, patients, databases, controlled trial

Identifiers

Local EPrints ID: 61685
URI: http://eprints.soton.ac.uk/id/eprint/61685
ISSN: 1460-2725
PURE UUID: f87f5abf-81d6-4fec-965d-6b0ee7ecccab

Catalogue record

Date deposited: 10 Sep 2008
Last modified: 17 Jul 2017 14:21

Export record

Altmetrics

Contributors

Author: S. Brien
Author: P. Prescott
Author: B. Coghlan
Author: N. Bashir
Author: G. Lewith

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×